Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 138.37% | -142.70% | 8.70% | 0.54% | -5.48% |
| Total Depreciation and Amortization | -4.24% | -2.51% | 0.18% | 1.83% | -7.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.58% | 96.97% | -27.15% | 136.55% | -56.36% |
| Change in Net Operating Assets | -110.71% | 512.32% | 228.25% | -52.84% | 191.80% |
| Cash from Operations | 260.90% | -17.04% | 24.29% | 15.33% | 6.54% |
| Capital Expenditure | -- | 124.07% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 124.07% | -- | -- | -- |
| Total Debt Issued | -- | -- | 100.00% | -100.09% | -- |
| Total Debt Repaid | -3,685.29% | 14.57% | -37.24% | 39.08% | -39.18% |
| Issuance of Common Stock | -- | -- | 48.08% | 59.79% | -41.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,225.00% | 114.04% | -280.00% | -76.47% | 43.33% |
| Cash from Financing | -167.57% | 56.41% | 135.74% | -46.54% | 75.48% |
| Foreign Exchange rate Adjustments | 270.00% | 94.90% | -443.86% | 58.33% | 164.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.15% | 226.14% | 137.92% | -50.56% | 56.10% |